Alleged anticompetitive conduct in generic pharmaceuticals market
Serving as lead consulting expert for the plaintiffs in a matter involving a pharmaceutical manufacturer that allegedly engaged in anticompetitive conduct resulting in the branded drug continuing to maintain majority market share despite the availability of generic substitutes.